Lucentis Market – Anti-VEGF Therapy Continues Treating...

добавлена новая статья Health

2026-07-21 07:48:17 -

Lucentis Market – Anti-VEGF Therapy Continues Treating Retinal Disease

Market Overview The Lucentis market remains an important segment within ophthalmic anti-VEGF therapy, used widely for treating age-related macular degeneration, diabetic macular edema, and other retinal vascular conditions. Growth through 2030 is shaped by an aging global population at higher risk of retinal disease, continued clinical reliance on established anti-VEGF therapies, and evolving...

0 Комментарии 0 Поделились 5 Просмотры 0 предпросмотр